Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45357Phase 4Active, not recruiting
Phase 4, randomised trial in hyperglycemia comparing Liraglutide with Placebo (2 arms). Primary endpoint: Reduction in the number of patients needing perioperative insulin treatment. Started Jun 2017; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45357.